Nuventra Pharma Sciences is now Allucent. Learn more here.

Take a deeper dive


Webinar | The Path to IND – Roadblocks, Milestones, and Regulatory Strategy

This event has passed. See all of our upcoming events, browse our Webinar Library for past presentations or, check out our Resource Library for blogs, case studies, news, toolkits and more. 

On November 14, Nuventra’s Todd Shearer and Brian Furmanski will lead a webinar titled “The Path to IND: Roadblocks, Milestones, and Regulatory Strategy.”

Key takeaways will include:

  • The basics of an IND
  • How to select your FIH dose
  • General study requirements for an IND
  • Pitfalls to avoid
  • Strategies for your pre-IND meeting
  • Tips for interacting with the FDA

Dr. Shearer has 16+ years of expertise in Pharmacokinetics, Toxicokinetics, Drug Metabolism, PK/PD, Nonclinical and Clinical Pharmacology, and Bioanalysis.

Dr. Furmanski has 10+ years of drug development experience and has recently spent 3 years as a reviewer at the FDA, where he reviewed and provided regulatory advice for over 200 INDs spanning across all phases of development.